WPRO B: Cost effectiveness results for Maternal and Neonatal Health
This Table provides summary results of the total population-level costs, effects and cost-effectiveness for the selected WHO sub-region and risk factor / disease for the year 2000.
KEY
I$ - International Dollars
Program Costs include costs of administration, media, training etc
Patient Costs include costs of hospital visits, drugs, etc
-
Summary
Summary of the methodologies used in the analysis -
Published research report
pdf, 167kb -
Excel Spreadsheet
xls, 93kb
Download this table in excel
| Interventions:Codes_and_Descriptions | Coverage | Cost per year (I$, millions) per one million_population [i.e. cost per capita] | % Program costs | % Patient costs | DALYs averted per year per one million_population | Average Cost per DALY averted | Incremental Cost per DALY averted |
| MNH-1: Community newborn care package | 50% | 0.05 | 24% | 76% | 2,439 | 20 | Dominated |
| MNH-2: Support for breastfeeding mothers | 50% | 0.05 | 21% | 79% | 2,301 | 22 | Dominated |
| MNH-3: Pre-eclampsia screening | 50% | 0.03 | 26% | 74% | 49 | 570 | Dominated |
| MNH-4: Tetanus toxoid | 50% | 0.03 | 22% | 78% | 1,984 | 16 | 16 |
| MNH-5: Screening & treatment of asymptomatic bacteriuria | 50% | 0.02 | 36% | 64% | 45 | 440 | Dominated |
| MNH-6: Screening & treatment of syphilis | 50% | 0.02 | 33% | 67% | 26 | 833 | Dominated |
| MNH-7: Normal delivery by a skilled attendant | 50% | 0.09 | 16% | 84% | 1,264 | 71 | Dominated |
| MNH-8: Community-based case management for neonatal pneumonia | 50% | 0.00 | 86% | 14% | 97 | 36 | Dominated |
| MNH-9: Normal delivery by a skilled attendant + Tetanus Toxoid | 50% | 0.12 | 14% | 86% | 2,200 | 54 | Dominated |
| MNH-10: Management of maternal sepsis | 50% | 0.07 | 3% | 97% | 9 | 7,386 | Dominated |
| MNH-11: Management of severe neonatal asphyxia | 50% | 0.03 | 53% | 47% | 9 | 2,842 | Dominated |
| MNH-12: Management of serious newborn infections | 50% | 0.08 | 17% | 83% | 121 | 670 | Dominated |
| MNH-13: Management of very low birth weight babies | 50% | 0.04 | 40% | 60% | 85 | 412 | Dominated |
| MNH-14: Manangement of neonatal jaundice | 50% | 0.03 | 56% | 44% | 3 | 9,357 | Dominated |
| MNH-15: Tetanus toxoid + Pre-eclampsia screening | 50% | 0.05 | 18% | 82% | 2,033 | 23 | Dominated |
| MNH-16: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 50% | 0.05 | 24% | 76% | 2,078 | 24 | Dominated |
| MNH-17: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 50% | 0.05 | 28% | 72% | 2,103 | 26 | Dominated |
| MNH-18: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 50% | 0.14 | 19% | 81% | 2,281 | 60 | Dominated |
| MNH-19: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 50% | 0.12 | 18% | 82% | 2,319 | 53 | Dominated |
| MNH-20: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 50% | 0.23 | 9% | 91% | 2,267 | 99 | Dominated |
| MNH-21: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 50% | 0.16 | 16% | 84% | 2,289 | 70 | Dominated |
| MNH-22: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 50% | 0.15 | 15% | 85% | 2,216 | 69 | Dominated |
| MNH-23: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 50% | 0.21 | 11% | 89% | 2,329 | 91 | Dominated |
| MNH-24: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 50% | 0.15 | 11% | 89% | 2,249 | 66 | Dominated |
| MNH-25: Management of vLBW + Management of serious newborn infections | 50% | 0.15 | 12% | 88% | 207 | 706 | Dominated |
| MNH-26: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 50% | 0.16 | 11% | 89% | 216 | 733 | Dominated |
| MNH-27: ENC | 50% | 0.17 | 11% | 89% | 226 | 762 | Dominated |
| MNH-28: ENC + Management of maternal sepsis | 50% | 0.26 | 8% | 92% | 228 | 1,116 | Dominated |
| MNH-29: Community newborn care package + Community-based pneumonia | 50% | 0.07 | 43% | 57% | 2,538 | 26 | Dominated |
| MNH-30: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 50% | 0.15 | 22% | 78% | 2,314 | 64 | Dominated |
| MNH-31: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 50% | 0.17 | 19% | 81% | 2,356 | 73 | Dominated |
| MNH-32: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 50% | 0.20 | 16% | 84% | 2,319 | 85 | Dominated |
| MNH-33: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 50% | 0.22 | 19% | 81% | 2,414 | 93 | Dominated |
| MNH-34: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 50% | 0.23 | 14% | 86% | 2,334 | 99 | Dominated |
| MNH-35: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 50% | 0.26 | 16% | 84% | 2,424 | 107 | Dominated |
| MNH-36: Community newborn care package + Tetanus Toxoid | 50% | 0.08 | 24% | 76% | 4,423 | 18 | Dominated |
| MNH-37: Community-based pneumonia + Tetanus Toxoid | 50% | 0.04 | 28% | 72% | 2,081 | 17 | Dominated |
| MNH-38: Community-based pneumonia + ANC | 50% | 0.06 | 32% | 68% | 2,201 | 26 | Dominated |
| MNH-39: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 50% | 0.10 | 36% | 64% | 4,521 | 22 | Dominated |
| MNH-40: Support for breastfeeding mothers + Tetanus toxoid | 50% | 0.08 | 22% | 78% | 4,285 | 19 | Dominated |
| MNH-41: Community newborn care package + ANC | 50% | 0.10 | 26% | 74% | 4,543 | 23 | Dominated |
| MNH-42: Community newborn care package + ANC + Community-based pneumonia | 50% | 0.12 | 36% | 64% | 4,641 | 26 | Dominated |
| MNH-43: Community newborn care package + ANC + Community-based pneumonia + SMNC | 50% | 0.24 | 32% | 68% | 5,052 | 47 | Dominated |
| MNH-44: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 50% | 0.16 | 37% | 63% | 4,727 | 33 | Dominated |
| MNH-45: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 50% | 0.37 | 22% | 78% | 5,123 | 72 | Dominated |
| MNH-46: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 50% | 0.27 | 33% | 67% | 5,137 | 53 | Dominated |
| MNH-47: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 50% | 0.26 | 29% | 71% | 5,094 | 51 | Dominated |
| MNH-48: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 50% | 0.35 | 23% | 77% | 5,223 | 68 | Dominated |
| MNH-49: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.37 | 21% | 79% | 5,161 | 71 | Dominated |
| MNH-50: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 50% | 0.44 | 18% | 82% | 5,174 | 86 | Dominated |
| MNH-51: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 50% | 0.30 | 30% | 70% | 5,179 | 57 | Dominated |
| MNH-52: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 50% | 0.12 | 35% | 65% | 4,616 | 25 | Dominated |
| MNH-53: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 50% | 0.43 | 22% | 78% | 5,319 | 81 | Dominated |
| MNH-54: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.37 | 21% | 79% | 5,161 | 71 | Dominated |
| MNH-55: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 50% | 0.10 | 24% | 76% | 4,518 | 22 | Dominated |
| MNH-56: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.50 | 17% | 83% | 5,338 | 94 | Dominated |
| MNH-57: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 50% | 0.44 | 18% | 82% | 5,290 | 83 | Dominated |
| MNH-58: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 50% | 0.37 | 20% | 80% | 5,168 | 72 | Dominated |
| MNH-59: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 50% | 0.40 | 19% | 81% | 5,166 | 77 | Dominated |
| MNH-60: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 50% | 0.38 | 21% | 79% | 5,176 | 74 | Dominated |
| MNH-61: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 50% | 0.52 | 18% | 82% | 5,386 | 96 | Dominated |
| MNH-62: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 50% | 0.61 | 16% | 84% | 5,516 | 111 | Dominated |
| MNH-63: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.18 | 20% | 80% | 4,720 | 39 | Dominated |
| MNH-64: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.50 | 17% | 83% | 5,313 | 93 | Dominated |
| MNH-65: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 50% | 0.61 | 16% | 84% | 5,516 | 111 | Dominated |
| MNH-66: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 50% | 0.57 | 17% | 83% | 5,392 | 106 | Dominated |
| MNH-67: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 50% | 0.54 | 17% | 83% | 5,394 | 101 | Dominated |
| MNH-68: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 50% | 0.66 | 15% | 85% | 5,521 | 120 | Dominated |
| MNH-69: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 50% | 0.64 | 16% | 84% | 5,524 | 115 | Dominated |
| MNH-70: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 50% | 0.65 | 16% | 84% | 5,532 | 117 | Dominated |
| MNH-71: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 50% | 0.70 | 14% | 86% | 5,536 | 126 | Dominated |
| MNH-72: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 50% | 0.69 | 15% | 85% | 5,529 | 124 | Dominated |
| MNH-73: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 50% | 0.72 | 14% | 86% | 5,544 | 130 | Dominated |
| MNH-74: Community newborn care package + Tetanus Toxoid + SMNC | 50% | 0.19 | 23% | 77% | 4,840 | 39 | Dominated |
| MNH-75: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.20 | 27% | 73% | 4,819 | 42 | Dominated |
| MNH-76: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 50% | 0.21 | 29% | 71% | 4,938 | 42 | Dominated |
| MNH-77: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.20 | 21% | 79% | 4,815 | 42 | Dominated |
| MNH-78: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.22 | 27% | 73% | 4,913 | 45 | Dominated |
| MNH-79: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 50% | 0.29 | 15% | 85% | 4,882 | 59 | Dominated |
| MNH-80: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.30 | 19% | 81% | 4,980 | 61 | Dominated |
| MNH-81: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 50% | 0.29 | 16% | 84% | 5,001 | 59 | Dominated |
| MNH-82: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.30 | 19% | 81% | 4,980 | 61 | Dominated |
| MNH-83: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 50% | 0.31 | 21% | 79% | 5,100 | 61 | Dominated |
| MNH-84: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 50% | 0.25 | 26% | 74% | 5,074 | 49 | Dominated |
| MNH-85: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 50% | 0.36 | 19% | 81% | 5,141 | 69 | Dominated |
| MNH-86: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 50% | 0.30 | 22% | 78% | 5,080 | 59 | Dominated |
| MNH-87: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 50% | 0.27 | 24% | 76% | 5,082 | 54 | Dominated |
| MNH-88: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 50% | 0.32 | 20% | 80% | 5,087 | 64 | Dominated |
| MNH-89: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.58 | 14% | 86% | 5,380 | 108 | Dominated |
| MNH-90: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.59 | 15% | 85% | 5,405 | 108 | Dominated |
| MNH-91: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 50% | 0.62 | 14% | 86% | 5,420 | 114 | Dominated |
| MNH-92: Community newborn care package | 80% | 0.08 | 27% | 73% | 3,903 | 21 | Dominated |
| MNH-93: Support for breastfeeding mothers | 80% | 0.08 | 24% | 76% | 3,682 | 23 | Dominated |
| MNH-94: Pre-eclampsia screening | 80% | 0.05 | 28% | 72% | 78 | 589 | Dominated |
| MNH-95: Tetanus toxoid | 80% | 0.05 | 24% | 76% | 3,174 | 17 | 17 |
| MNH-96: Screening & treatment of asymptomatic bacteriuria | 80% | 0.03 | 39% | 61% | 73 | 455 | Dominated |
| MNH-97: Screening & treatment of syphilis | 80% | 0.04 | 35% | 65% | 42 | 860 | Dominated |
| MNH-98: Normal delivery by a skilled attendant | 80% | 0.15 | 18% | 82% | 2,022 | 73 | Dominated |
| MNH-99: Community-based case management for neonatal pneumonia | 80% | 0.00 | 80% | 20% | 155 | 26 | Dominated |
| MNH-100: Normal delivery by a skilled attendant + Tetanus Toxoid | 80% | 0.19 | 17% | 83% | 3,520 | 55 | Dominated |
| MNH-101: Management of maternal sepsis | 80% | 0.12 | 3% | 97% | 15 | 7,800 | Dominated |
| MNH-102: Management of severe neonatal asphyxia | 80% | 0.05 | 55% | 45% | 15 | 3,202 | Dominated |
| MNH-103: Management of serious newborn infections | 80% | 0.14 | 19% | 81% | 194 | 724 | Dominated |
| MNH-104: Management of very low birth weight babies | 80% | 0.06 | 43% | 57% | 137 | 458 | Dominated |
| MNH-105: Manangement of neonatal jaundice | 80% | 0.05 | 58% | 42% | 4 | 10,611 | Dominated |
| MNH-106: Tetanus toxoid + Pre-eclampsia screening | 80% | 0.07 | 19% | 81% | 3,252 | 23 | Dominated |
| MNH-107: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 80% | 0.08 | 25% | 75% | 3,325 | 24 | Dominated |
| MNH-108: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 80% | 0.09 | 30% | 70% | 3,365 | 27 | Dominated |
| MNH-109: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 80% | 0.22 | 22% | 78% | 3,650 | 61 | Dominated |
| MNH-110: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 80% | 0.21 | 21% | 79% | 3,711 | 55 | Dominated |
| MNH-111: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 80% | 0.38 | 10% | 90% | 3,627 | 106 | Dominated |
| MNH-112: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 80% | 0.25 | 20% | 80% | 3,662 | 69 | Dominated |
| MNH-113: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 80% | 0.25 | 16% | 84% | 3,545 | 71 | Dominated |
| MNH-114: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 80% | 0.36 | 12% | 88% | 3,727 | 96 | Dominated |
| MNH-115: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 80% | 0.25 | 13% | 87% | 3,599 | 69 | Dominated |
| MNH-116: Management of vLBW + Management of serious newborn infections | 80% | 0.25 | 13% | 87% | 331 | 754 | Dominated |
| MNH-117: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 80% | 0.27 | 12% | 88% | 346 | 783 | Dominated |
| MNH-118: Emergency neonatal care | 80% | 0.29 | 12% | 88% | 361 | 813 | Dominated |
| MNH-119: ENC + Management of maternal sepsis | 80% | 0.43 | 9% | 91% | 366 | 1,184 | Dominated |
| MNH-120: Community newborn care package + Community-based pneumonia | 80% | 0.09 | 35% | 65% | 4,060 | 23 | Dominated |
| MNH-121: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 80% | 0.24 | 25% | 75% | 3,702 | 66 | Dominated |
| MNH-122: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 80% | 0.28 | 22% | 78% | 3,769 | 74 | Dominated |
| MNH-123: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 80% | 0.32 | 19% | 81% | 3,711 | 85 | Dominated |
| MNH-124: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 80% | 0.38 | 22% | 78% | 3,863 | 99 | Dominated |
| MNH-125: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 80% | 0.36 | 17% | 83% | 3,734 | 98 | Dominated |
| MNH-126: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 80% | 0.44 | 19% | 81% | 3,878 | 113 | Dominated |
| MNH-127: Community newborn care package + Tetanus Toxoid | 80% | 0.13 | 26% | 74% | 7,077 | 19 | 21 |
| MNH-128: Community-based pneumonia + Tetanus Toxoid | 80% | 0.06 | 28% | 72% | 3,329 | 17 | Dominated |
| MNH-129: Community-based pneumonia + ANC | 80% | 0.09 | 32% | 68% | 3,521 | 27 | Dominated |
| MNH-130: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 80% | 0.15 | 31% | 69% | 7,234 | 20 | Dominated |
| MNH-131: Support for breastfeeding mothers + Tetanus toxoid | 80% | 0.14 | 24% | 76% | 6,856 | 20 | Dominated |
| MNH-132: Community newborn care package + ANC | 80% | 0.17 | 28% | 72% | 7,269 | 23 | Dominated |
| MNH-133: Community newborn care package + ANC + Community-based pneumonia | 80% | 0.18 | 32% | 68% | 7,426 | 25 | Dominated |
| MNH-134: Community newborn care package + ANC + Community-based pneumonia + SMNC | 80% | 0.38 | 32% | 68% | 8,083 | 47 | Dominated |
| MNH-135: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 80% | 0.24 | 35% | 65% | 7,562 | 32 | Dominated |
| MNH-136: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 80% | 0.57 | 23% | 77% | 8,196 | 70 | Dominated |
| MNH-137: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 80% | 0.44 | 34% | 66% | 8,220 | 54 | Dominated |
| MNH-138: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 80% | 0.41 | 30% | 70% | 8,150 | 50 | Dominated |
| MNH-139: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 80% | 0.58 | 23% | 77% | 8,357 | 69 | Dominated |
| MNH-140: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.60 | 21% | 79% | 8,257 | 73 | Dominated |
| MNH-141: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 80% | 0.70 | 18% | 82% | 8,278 | 85 | Dominated |
| MNH-142: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 80% | 0.47 | 31% | 69% | 8,287 | 57 | Dominated |
| MNH-143: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 80% | 0.17 | 30% | 70% | 7,386 | 24 | Dominated |
| MNH-144: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 80% | 0.70 | 22% | 78% | 8,511 | 83 | Dominated |
| MNH-145: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.60 | 21% | 79% | 8,257 | 73 | Dominated |
| MNH-146: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 80% | 0.16 | 26% | 74% | 7,229 | 22 | Dominated |
| MNH-147: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 0.79 | 18% | 82% | 8,541 | 93 | Dominated |
| MNH-148: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 80% | 0.72 | 19% | 81% | 8,464 | 85 | Dominated |
| MNH-149: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 80% | 0.58 | 21% | 79% | 8,269 | 71 | Dominated |
| MNH-150: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 80% | 0.62 | 20% | 80% | 8,266 | 76 | Dominated |
| MNH-151: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 80% | 0.61 | 21% | 79% | 8,282 | 74 | Dominated |
| MNH-152: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 80% | 0.85 | 19% | 81% | 8,618 | 98 | Dominated |
| MNH-153: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 80% | 1.01 | 17% | 83% | 8,825 | 115 | Dominated |
| MNH-154: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.30 | 24% | 76% | 7,553 | 40 | Dominated |
| MNH-155: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 0.78 | 17% | 83% | 8,501 | 92 | Dominated |
| MNH-156: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 80% | 1.01 | 17% | 83% | 8,825 | 115 | Dominated |
| MNH-157: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 80% | 0.92 | 17% | 83% | 8,627 | 106 | Dominated |
| MNH-158: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 80% | 0.88 | 18% | 82% | 8,631 | 102 | Dominated |
| MNH-159: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 80% | 1.08 | 16% | 84% | 8,834 | 123 | Dominated |
| MNH-160: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 80% | 1.04 | 16% | 84% | 8,838 | 118 | Dominated |
| MNH-161: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.07 | 16% | 84% | 8,851 | 121 | Dominated |
| MNH-162: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.13 | 15% | 85% | 8,857 | 128 | Dominated |
| MNH-163: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 80% | 1.11 | 15% | 85% | 8,846 | 126 | Dominated |
| MNH-164: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 80% | 1.16 | 15% | 85% | 8,870 | 131 | Dominated |
| MNH-165: Community newborn care package + Tetanus Toxoid + SMNC | 80% | 0.32 | 26% | 74% | 7,744 | 41 | Dominated |
| MNH-166: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.32 | 26% | 74% | 7,710 | 41 | Dominated |
| MNH-167: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 80% | 0.33 | 29% | 71% | 7,901 | 41 | Dominated |
| MNH-168: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.33 | 24% | 76% | 7,704 | 43 | Dominated |
| MNH-169: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.34 | 26% | 74% | 7,861 | 44 | Dominated |
| MNH-170: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 80% | 0.48 | 17% | 83% | 7,811 | 61 | Dominated |
| MNH-171: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.49 | 19% | 81% | 7,968 | 61 | Dominated |
| MNH-172: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 80% | 0.49 | 19% | 81% | 8,002 | 61 | Dominated |
| MNH-173: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.49 | 19% | 81% | 7,968 | 61 | Dominated |
| MNH-174: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 80% | 0.50 | 20% | 80% | 8,159 | 61 | Dominated |
| MNH-175: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 80% | 0.39 | 26% | 74% | 8,119 | 48 | Dominated |
| MNH-176: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 80% | 0.58 | 18% | 82% | 8,226 | 70 | Dominated |
| MNH-177: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 80% | 0.46 | 22% | 78% | 8,128 | 56 | Dominated |
| MNH-178: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 80% | 0.42 | 24% | 76% | 8,131 | 51 | Dominated |
| MNH-179: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 80% | 0.49 | 21% | 79% | 8,140 | 60 | Dominated |
| MNH-180: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 0.93 | 15% | 85% | 8,608 | 107 | Dominated |
| MNH-181: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 0.93 | 15% | 85% | 8,648 | 108 | Dominated |
| MNH-182: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 80% | 0.98 | 15% | 85% | 8,672 | 113 | Dominated |
| MNH-183: Community newborn care package | 95% | 0.10 | 28% | 72% | 4,635 | 21 | Dominated |
| MNH-184: Support for breastfeeding mothers | 95% | 0.10 | 25% | 75% | 4,373 | 23 | Dominated |
| MNH-185: Pre-eclampsia screening | 95% | 0.06 | 29% | 71% | 92 | 638 | Dominated |
| MNH-186: Tetanus toxoid | 95% | 0.07 | 25% | 75% | 3,769 | 18 | Dominated |
| MNH-187: Screening & treatment of asymptomatic bacteriuria | 95% | 0.04 | 40% | 60% | 86 | 498 | Dominated |
| MNH-188: Screening & treatment of syphilis | 95% | 0.05 | 37% | 63% | 50 | 934 | Dominated |
| MNH-190: Normal delivery by a skilled attendant | 95% | 0.18 | 21% | 79% | 2,401 | 76 | Dominated |
| MNH-191: Community-based case management for neonatal pneumonia | 95% | 0.00 | 78% | 22% | 184 | 23 | Dominated |
| MNH-193: Normal delivery by a skilled attendant + Tetanus Toxoid | 95% | 0.24 | 19% | 81% | 4,180 | 58 | Dominated |
| MNH-194: Management of maternal sepsis | 95% | 0.16 | 3% | 97% | 18 | 8,837 | Dominated |
| MNH-195: Management of severe neonatal asphyxia | 95% | 0.07 | 56% | 44% | 18 | 3,739 | Dominated |
| MNH-196: Management of serious newborn infections | 95% | 0.19 | 20% | 80% | 231 | 830 | Dominated |
| MNH-197: Management of very low birth weight babies | 95% | 0.09 | 44% | 56% | 162 | 532 | Dominated |
| MNH-198: Manangement of neonatal jaundice | 95% | 0.06 | 59% | 41% | 5 | 12,483 | Dominated |
| MNH-199: Tetanus toxoid + Pre-eclampsia screening | 95% | 0.10 | 20% | 80% | 3,862 | 25 | Dominated |
| MNH-200: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 95% | 0.10 | 26% | 74% | 3,949 | 26 | Dominated |
| MNH-201: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 95% | 0.11 | 31% | 69% | 3,997 | 29 | Dominated |
| MNH-202: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 95% | 0.28 | 26% | 74% | 4,334 | 64 | Dominated |
| MNH-203: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 95% | 0.26 | 24% | 76% | 4,407 | 58 | Dominated |
| MNH-204: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 95% | 0.52 | 10% | 90% | 4,307 | 121 | Dominated |
| MNH-205: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 95% | 0.31 | 23% | 77% | 4,349 | 71 | Dominated |
| MNH-206: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 95% | 0.33 | 18% | 82% | 4,210 | 78 | Dominated |
| MNH-207: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 95% | 0.48 | 13% | 87% | 4,426 | 109 | Dominated |
| MNH-208: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 95% | 0.32 | 14% | 86% | 4,274 | 75 | Dominated |
| MNH-209: Management of vLBW + Management of serious newborn infections | 95% | 0.34 | 13% | 87% | 393 | 860 | Dominated |
| MNH-210: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 95% | 0.37 | 12% | 88% | 411 | 893 | Dominated |
| MNH-211: Emergency neonatal care | 95% | 0.40 | 12% | 88% | 429 | 927 | Dominated |
| MNH-212: ENC + Management of maternal sepsis | 95% | 0.58 | 9% | 91% | 434 | 1,339 | Dominated |
| MNH-213: Community newborn care package + Community-based pneumonia | 95% | 0.11 | 33% | 67% | 4,821 | 22 | Dominated |
| MNH-214: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 95% | 0.31 | 27% | 73% | 4,396 | 70 | Dominated |
| MNH-215: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 95% | 0.35 | 24% | 76% | 4,476 | 78 | Dominated |
| MNH-216: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 95% | 0.39 | 21% | 79% | 4,407 | 89 | Dominated |
| MNH-217: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 95% | 0.50 | 24% | 76% | 4,588 | 108 | Dominated |
| MNH-218: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 95% | 0.46 | 18% | 82% | 4,435 | 103 | Dominated |
| MNH-219: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 95% | 0.58 | 21% | 79% | 4,605 | 126 | Dominated |
| MNH-221: Community newborn care package + Tetanus Toxoid | 95% | 0.17 | 27% | 73% | 8,404 | 20 | 24 |
| MNH-222: Community-based pneumonia + Tetanus Toxoid | 95% | 0.07 | 28% | 72% | 3,954 | 18 | Dominated |
| MNH-223: Community-based pneumonia + ANC | 95% | 0.12 | 32% | 68% | 4,181 | 28 | Dominated |
| MNH-224: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 95% | 0.17 | 30% | 70% | 8,591 | 20 | 42 |
| MNH-225: Support for breastfeeding mothers + Tetanus toxoid | 95% | 0.17 | 25% | 75% | 8,142 | 21 | Dominated |
| MNH-227: Community newborn care package + ANC | 95% | 0.21 | 30% | 70% | 8,631 | 25 | Dominated |
| MNH-228: Community newborn care package + ANC + Community-based pneumonia | 95% | 0.22 | 32% | 68% | 8,818 | 25 | 220 |
| MNH-229: Community newborn care package + ANC + Community-based pneumonia + SMNC | 95% | 0.46 | 34% | 66% | 9,599 | 48 | Dominated |
| MNH-230: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 95% | 0.31 | 35% | 65% | 8,980 | 34 | Dominated |
| MNH-232: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 95% | 0.71 | 24% | 76% | 9,733 | 73 | Dominated |
| MNH-233: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.55 | 36% | 64% | 9,761 | 56 | Dominated |
| MNH-235: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 95% | 0.51 | 31% | 69% | 9,678 | 52 | Dominated |
| MNH-236: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 95% | 0.75 | 23% | 77% | 9,924 | 75 | Dominated |
| MNH-237: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 0.79 | 21% | 79% | 9,805 | 80 | Dominated |
| MNH-240: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 95% | 0.91 | 18% | 82% | 9,830 | 92 | Dominated |
| MNH-241: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 95% | 0.59 | 33% | 67% | 9,841 | 60 | 586 |
| MNH-242: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 95% | 0.21 | 29% | 71% | 8,770 | 24 | 198 |
| MNH-243: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 95% | 0.90 | 23% | 77% | 10,107 | 89 | Dominated |
| MNH-244: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 0.79 | 21% | 79% | 9,805 | 80 | Dominated |
| MNH-245: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 95% | 0.20 | 27% | 73% | 8,584 | 24 | Dominated |
| MNH-246: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.00 | 19% | 81% | 10,143 | 99 | Dominated |
| MNH-247: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 95% | 0.93 | 19% | 81% | 10,051 | 93 | Dominated |
| MNH-248: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 95% | 0.73 | 22% | 78% | 9,820 | 74 | Dominated |
| MNH-249: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 95% | 0.78 | 20% | 80% | 9,815 | 80 | Dominated |
| MNH-250: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 95% | 0.78 | 22% | 78% | 9,835 | 80 | Dominated |
| MNH-251: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 95% | 1.09 | 19% | 81% | 10,234 | 107 | Dominated |
| MNH-252: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 95% | 1.33 | 17% | 83% | 10,480 | 127 | 1,481 |
| MNH-253: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.38 | 26% | 74% | 8,969 | 42 | Dominated |
| MNH-254: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 0.99 | 18% | 82% | 10,095 | 98 | Dominated |
| MNH-255: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 95% | 1.33 | 17% | 83% | 10,480 | 127 | Dominated |
| MNH-256: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 95% | 1.18 | 18% | 82% | 10,244 | 115 | Dominated |
| MNH-257: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 95% | 1.12 | 18% | 82% | 10,249 | 110 | Dominated |
| MNH-258: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 95% | 1.42 | 16% | 84% | 10,490 | 135 | Dominated |
| MNH-259: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 95% | 1.36 | 16% | 84% | 10,495 | 130 | 2,207 |
| MNH-260: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 95% | 1.42 | 17% | 83% | 10,510 | 135 | 3,583 |
| MNH-261: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 95% | 1.48 | 15% | 85% | 10,518 | 141 | Dominated |
| MNH-262: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 95% | 1.45 | 15% | 85% | 10,505 | 138 | Dominated |
| MNH-263: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 95% | 1.51 | 15% | 85% | 10,533 | 144 | 4,176 |
| MNH-264: Community newborn care package + Tetanus Toxoid + SMNC | 95% | 0.39 | 29% | 71% | 9,196 | 42 | Dominated |
| MNH-265: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.38 | 28% | 72% | 9,155 | 42 | Dominated |
| MNH-266: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 95% | 0.40 | 30% | 70% | 9,382 | 42 | Dominated |
| MNH-267: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.41 | 26% | 74% | 9,149 | 45 | Dominated |
| MNH-268: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.42 | 28% | 72% | 9,335 | 45 | Dominated |
| MNH-269: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 95% | 0.60 | 18% | 82% | 9,276 | 65 | Dominated |
| MNH-270: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 0.61 | 19% | 81% | 9,462 | 64 | Dominated |
| MNH-271: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 95% | 0.61 | 20% | 80% | 9,503 | 65 | Dominated |
| MNH-272: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 0.61 | 19% | 81% | 9,462 | 64 | Dominated |
| MNH-273: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 95% | 0.62 | 21% | 79% | 9,689 | 64 | Dominated |
| MNH-274: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 95% | 0.48 | 27% | 73% | 9,641 | 49 | 310 |
| MNH-275: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 95% | 0.76 | 18% | 82% | 9,769 | 78 | Dominated |
| MNH-276: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 95% | 0.56 | 23% | 77% | 9,651 | 58 | Dominated |
| MNH-277: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 95% | 0.51 | 26% | 74% | 9,656 | 53 | Dominated |
| MNH-278: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 95% | 0.59 | 22% | 78% | 9,666 | 61 | Dominated |
| MNH-279: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.18 | 15% | 85% | 10,222 | 115 | Dominated |
| MNH-280: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.19 | 16% | 84% | 10,270 | 116 | Dominated |
| MNH-281: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 95% | 1.25 | 15% | 85% | 10,298 | 122 | Dominated |
| MNH-282: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 0.79 | 27% | 73% | 10,007 | 79 | Dominated |
| MNH-283: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.48 | 33% | 67% | 9,545 | 51 | Dominated |
| MNH-284: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 0.72 | 24% | 76% | 9,790 | 74 | Dominated |
| MNH-285: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term + Treatment of severe PEE | 95% | 0.83 | 25% | 75% | 10,086 | 82 | 972 |
| MNH-286: Community newborn care package + ANC + Community-based pneumonia + SMNC + ENC + Steroids pre-term + Treatment of severe PEE | 95% | 1.14 | 19% | 81% | 10,353 | 110 | 1,168 |